Estefanía
Pérez Lopez
Investigadora desde 2016
Publicaciones (16) Publicaciones de Estefanía Pérez Lopez
2024
-
A research center’s experience of T-cell–redirecting therapies in triple-class refractory multiple myeloma
Blood Advances, Vol. 8, Núm. 13, pp. 3478-3487
-
Impact of the kinetics of circulating anti-CD19 CAR-T cells and their populations on the outcome of DLBCL patients
Blood cancer journal
-
Ofatumumab as part of reduced intensity conditioning in high risk B-cell lymphoma patients: final long-term analysis from a prospective multicenter Phase-II Trial
Bone Marrow Transplantation
-
Treatment of post-allogeneic hematopoietic stem cell transplant cytopenias with sequential doses of multipotent mesenchymal stromal/stem cells
Cytotherapy, Vol. 26, Núm. 8, pp. 806-812
2023
2022
-
Graft versus host disease-related eosinophilic fasciitis: cohort description and literature review
Advances in Rheumatology, Vol. 62, Núm. 1
2020
-
Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation
Bone Marrow Transplantation, Vol. 55, Núm. 2, pp. 419-430
2017
-
Phase II Study of Yttrium-90-Ibritumomab Tiuxetan as Part of Reduced-Intensity Conditioning (with Melphalan, Fludarabine ± Thiotepa) for Allogeneic Transplantation in Relapsed or Refractory Aggressive B Cell Lymphoma: A GELTAMO Trial
Biology of Blood and Marrow Transplantation, Vol. 23, Núm. 1, pp. 53-59
2016
-
Minimal residual disease evaluation by flow cytometry is a complementary tool to cytogenetics for treatment decisions in acute myeloid leukaemia
Leukemia Research, Vol. 40, pp. 1-9
-
Potential protective effect of Helicobacter pylori on the development of gastrointestinal GvHD
Bone Marrow Transplantation, Vol. 51, Núm. 6, pp. 819-824
2014
-
Diagnostic utility of bone marrow examination for the assessment of patients with fever of unknown origin: A 10-year single-centre experience
Internal Medicine Journal, Vol. 44, Núm. 6, pp. 610-612
-
ESHAP as salvage therapy for relapsed or refractory Hodgkin's lymphoma
Annals of hematology, Vol. 93, Núm. 10, pp. 1745-1753
-
Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus
Bone Marrow Transplantation, Vol. 49, Núm. 5, pp. 684-690
2013
-
Analysis of incidence, risk factors and clinical outcome of thromboembolic and bleeding events in 431 allogeneic hematopoietic stem cell transplantation recipients
Haematologica, Vol. 98, Núm. 3, pp. 437-443
2010
-
Influence of the C677T mutation in methylenetetrahydrofolate reductase gene in venous thromboembolic disease
Angiologia, Vol. 62, Núm. 6, pp. 225-231